In global diplomacy, transparency is more than just a principle-it is an essential foundation for trust. When powerful nations like the United States negotiate agreements with developing countries, especially in sensitive sectors such as public health, clarity and openness are critical. Yet, recent reports indicate that Washington has pursued a series of secretive health agreements with multiple African nations, raising serious ethical, political, and humanitarian questions. What is being presented as a modernization of foreign assistance now appears, in some cases, to serve broader strategic objectives that may undermine the very countries these agreements are intended to help.

According to investigative reporting, the United States has signed at least 28 international health agreements, primarily with African nations such as Kenya, Uganda, Mozambique, Nigeria, and Ethiopia. These agreements reportedly involve $12.7 billion in US assistance, along with a requirement that partner countries invest an additional $7.8 billion. While these sums are substantial, the secrecy surrounding the agreements has caused alarm among governments, advocacy groups, and transparency watchdogs.

Central to the concern is the question of what the United States expects in return. Health assistance should primarily aim to improve medical care and address critical public health challenges. Yet critics argue that the undisclosed nature of these agreements suggests they may contain conditions unrelated to health, potentially placing partner nations at a strategic disadvantage. The fear is that aid may be used as a tool to extract political or economic concessions rather than as a genuine humanitarian effort.

The situation in Zambia offers a stark example. Reports indicate that negotiations over health assistance became linked to access to Zambia’s critical minerals, resources essential for technologies such as batteries, electronics, and renewable energy solutions. Allegations suggest that Washington considered withholding life-saving aid for the country’s 1.3 million HIV/AIDS patients as leverage to secure mineral concessions. While American officials have denied these claims, asserting that the US does not seek anything against Zambian laws or interests, the very notion that essential medical support could be politicized has sparked outrage.

Such claims underline a fundamental ethical problem. If health assistance is tied to unrelated policy objectives, the most vulnerable populations-those dependent on aid for survival-bear the brunt. Using medical aid as a negotiating tool transforms it from a humanitarian measure into a form of coercion. This approach, critics warn, risks undermining trust and eroding the credibility of American aid programs.

Transparency advocates have been particularly vocal. Organizations such as Public Citizen have filed lawsuits seeking access to the text of agreements negotiated under the Trump administration. They argue that without full disclosure, it is impossible to evaluate whether the agreements are fair or whether the terms impose undue burdens on partner countries. The broader principle is clear: secrecy in international agreements invites suspicion and can undermine the effectiveness of aid.

Resistance to these agreements is emerging across the continent. Zimbabwe recently rejected a $367 million US health funding proposal, calling it “lopsided” and lacking mutual respect. In Kenya, the High Court temporarily suspended a five-year health cooperation deal worth over $1.6 billion, citing concerns that it could expose sensitive medical information of Kenyan citizens to unlawful access. These actions demonstrate a growing insistence on transparency, fairness, and respect for national sovereignty. African governments increasingly recognize that they must carefully evaluate international partnerships rather than accept aid unconditionally.

The backlash also signals a broader shift in African diplomacy. Countries are asserting their right to equitable partnerships, demanding clarity, and scrutinizing the terms of foreign assistance. For decades, foreign aid has been criticized for creating dependency, imposing donor priorities, or advancing political agendas under the guise of development. The current controversy may represent a turning point in challenging these practices, emphasizing accountability and mutual benefit.

The United States must consider the long-term consequences of its approach. Africa is a continent of enormous strategic importance, both for its natural resources and its growing population. Building durable partnerships requires trust, and trust is impossible to maintain in an environment of secrecy. If African nations perceive American aid as conditional or transactional, they may increasingly turn to other partners. China, for example, has expanded its presence across Africa, often offering investment and infrastructure deals with fewer political conditions, even if the benefits of such agreements are debated.

It is important to note that accountability and results in aid programs are legitimate goals. Donor countries have a right to ensure that funds are used effectively. However, there is a critical distinction between ensuring transparency and measurable outcomes versus using aid as a bargaining tool for unrelated objectives. The former strengthens partnerships; the latter risks undermining them.

Moving forward, several steps are essential. First, all agreements should be fully disclosed, allowing governments, civil society, and citizens to examine and understand the terms. Second, the primary focus of health assistance must remain on improving medical care and public health outcomes. Any additional conditions should be directly related to these objectives and clearly justified. Finally, negotiations must be conducted in good faith, with respect for partner nations’ sovereignty, rather than through coercion or leverage.

At its core, the controversy over these “secret” health deals is about values as much as policy. It raises fundamental questions about how powerful nations engage with less powerful ones and whether aid can remain genuinely humanitarian in an increasingly strategic world. For the United States, the challenge is to demonstrate that its commitment to global health is principled, transparent, and focused on shared human benefit. Anything less risks turning aid into leverage and goodwill into distrust.

The international community, African governments, and American policymakers must take this controversy as a warning. Humanitarian assistance should never be treated as a bargaining chip, and transparency is not optional-it is a moral and political imperative. Without these commitments, the very programs designed to save lives could instead erode trust, deepen inequalities, and compromise the credibility of global health diplomacy.

Please follow Blitz on Google News Channel

© Blitz